Detalhe da pesquisa
1.
Peg-interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti-HBV efficacy and long-term survival among HBV DNA-positive hepatocellular carcinoma patients after hepatectomy/ablation.
J Viral Hepat
; 27(4): 387-396, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755220
2.
Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose.
Liver Int
; 34(10): 1522-31, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25453135
3.
Regulatory polymorphism of CXCL10 rs1439490 in seronegative occult hepatitis C virus infection.
World J Gastroenterol
; 24(20): 2191-2202, 2018 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29853737
4.
The relationship between ITPA rs1127354 polymorphisms and efficacy of antiviral treatment in Northeast Chinese CHC patients.
Medicine (Baltimore)
; 96(29): e7554, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28723780